Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by investclubon Aug 19, 2019 10:36pm
138 Views
Post# 30045235

RE:RE:RE:The lids going to blow on this

RE:RE:RE:The lids going to blow on this Hempdoc wrote
Longholder99 wrote: I agree Guisep. I've been around this stock for many years. Haven't seen this sustained high volume in Theralase shares that I can recall. A day or so of big numbers but not day after day. I'm hopeful that enough big dogs have skin in the game now to prevent short shenanigans. A cashed up oncology company with disruptive tech like this..and has only had money as its problem before now has that issue addressed. The tech works and can be applied to many indications. It is a cashflow generating beast for years to come with licenses and patentz. Once we get the green light in the States I'm not sure if the SP can be held back. Big Pharm must be aware and I wonder if the discussions are already taking place?


Agree...& I’m pretty sure Big Pharma has taken a closer look at this point, especially Merck, considering their subsidiary manufactures our product.  I’m sure Merck has a bit of a lazy eye these days with one eye firmly on Keytruda & the other on TLD-1433.  They’d be fools if they didn’t.  Good luck...
________________________________________________________________________________

Big pharma didn't get big on luck they as you have stated Merck has taken a look I would strongly suggest so has almost all and I also suggest their have picked up a healthy position in Theralase. A good strategy for them would be hold a small chunk and if ph2 looks good pick up more before the share price gets ridiculous ... the reason is cost I.e. you won't have to buy what you already hold should you decide to make an offer. Problem is the other pharmas that are holding positions and that's when we will see the bidding war. I guess it doesn't matter if my thoughts are right are if Joe or Pete or Bill or Sue we all can see gosh golly good returns starting very soon and I still say its financial funds and big pharma behind most of the shorting!!

Bullboard Posts